AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TELMISARTAN AND HYDROCHLOROTHIAZIDE
7 registrations across 3 African markets— 7 active
Markets with TELMISARTAN AND HYDROCHLOROTHIAZIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TELSWIFT H 80 TABLETS | 🇷🇼Rwanda | IND SWIFT LIMITED | active | May 2030 |
| CDTEL-H Tablets | 🇷🇼Rwanda | ZOTA HEALTHCARE LTD | active | Sept 2029 |
| VELMI-H Tablet | 🇰🇪Kenya | Eastleigh Pharmaceuticals Co. Ltd | active | Nov 2028 |
| VELMI-H PLUS Tablet | 🇰🇪Kenya | EASTLEIGH PHARMACEUTICAL COMPANY LIMITED | active | Oct 2028 |
| TELMISIN-H Tablets | 🇹🇿Tanzania | Lincoln Pharmaceuticals Limited | active | — |
| Telmiclar HTZ 40/12.5 Oral tablet | 🇹🇿Tanzania | Ajanta Pharma Limited | active | — |
| Telmiclar HTZ 80/12.5 Oral tablet | 🇹🇿Tanzania | Ajanta Pharma Limited | active | — |
TELMISARTAN AND HYDROCHLOROTHIAZIDE in Africa — Regulatory Overview
TELMISARTAN AND HYDROCHLOROTHIAZIDE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Kenya, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.